Approvals/TGA/FLUAD QUAD inactivated quadrivalent influenza vaccine (surface antigen) adjuvanted suspension for injection 60 mcg HA/ 0.5 mL PFS with attached needle, 2025 Season

Approved

STANDARD

FLUAD QUAD inactivated quadrivalent influenza vaccine (surface antigen) adjuvanted suspension for injection 60 mcg HA/ 0.5 mL PFS with attached needle, 2025 Season

Seqirus Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Date: May 30, 2025
Approval ID: e7d81d1528f9ac58
Company: Seqirus Pty Ltd
Type: Standard

Approval Details

Approval Id: e7d81d1528f9ac58
Product Name: FLUAD QUAD inactivated quadrivalent influenza vaccine (surface antigen) adjuvanted suspension for injection 60 mcg HA/ 0.5 mL PFS with attached needle, 2025 Season
Artg Id: 316323
Artg Name: FLUAD QUAD inactivated quadrivalent influenza vaccine (surface antigen) adjuvanted suspension for injection 60 mcg HA/ 0.5 mL PFS with attached needle
Sponsor: Seqirus Pty Ltd
Company Detail Path: /organization/seqirus-pty-ltd
Artg Date: 2019-09-30
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/b1a042453e06b91903538a7a6477cc2c.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/af917acdbf5335053abded644c87b884.pdf

Active Ingredients

Approved

Quick Info

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

e7d81d1528f9ac58

Type

Standard

Back to TGA Approvals